TNBIOTCGrain Mill ProductsFiscal year ends December 31
Tanke Biosciences Corp
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
Tanke Biosciences Corp revenue by segment
By business segment
| Revenue | FY2012 | FY2011 | % of revenue | YoY |
|---|---|---|---|---|
| Organic Trace Mineral Additives [Member] | $24.59M | $18.86M | 86.1% | +30.4% |
| Functional Regulation Additives [Member] | $3.06M | $4.16M | 10.7% | -26.6% |
| Other [Member] | $623.33K | $531.91K | 2.2% | +17.2% |
| Herbal Medicinal Additives [Member] | $293.45K | $281.04K | 1.0% | +4.4% |
By product or service
By region
From the segment and revenue-disaggregation notes of Tanke Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.